Burden and economic impact of RSV hospitalisations among English adults, 2023/24 - PubMed
5 hours ago
- #underdiagnosis
- #hospitalisation costs
- #RSV burden
- Provides national estimates for RSV hospitalizations among adults aged ≥40 in England for the 2023/24 season.
- Uses Hospital Episode Statistics (HES) and ICD-10 codes to identify RSV, influenza, and COVID-19 admissions.
- After adjusting for under-recognition, estimates 23,407 RSV admissions (75.9 per 100,000 population) costing £68.5 million.
- Incidence increases with age, peaking in adults aged ≥85, with significant costs also in the 40-74 age group.
- Highlights under-diagnosis and calls for improved testing, coding, and surveillance to guide vaccination policies.